Skip to Content

M 545 (Mirtazapine 45 mg)

Pill with imprint M 545 is Beige, Round and has been identified as Mirtazapine 45 mg. It is supplied by Mylan Pharmaceuticals Inc..

Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 545

Mirtazapine 45 mg M 545
Mirtazapine 45 mg M 545
Mirtazapine 45 mg M 545

Mirtazapine

Imprint
M 545
Strength
45 mg
Color
Beige
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Tetracyclic antidepressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
lactose anhydrous, silicon dioxide, croscarmellose sodium, FD&C Blue No. 2, FD&C Yellow No. 6, hypromelloses, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, corn starch, sodium lauryl sulfate, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-3545 Mylan Pharmaceuticals Inc.
51079-0088 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.